According to RVL Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is $36.91 Million USD. In 2022 the company made a revenue of $49.72 Million USD an increase over the revenue in the year 2021 that were of $40.44 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.